ColoradoExempt Drugs from Prescription Drug Affordability Board Reviews
What it does
The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Apr 22House Committee on Health & Human Services Postpone IndefinitelyLatest
- Vote recorded Lay over the bill until May 15th. Result: pass.Lower
- Apr 21Introduced In House - Assigned to Health & Human ServicesMinor
- Apr 13Senate Third Reading Passed - No AmendmentsPassed Senate
- Vote recorded BILL. Result: pass.Upper
- Apr 10Senate Third Reading Laid Over to 04/13/2026 - No Amendments
- Apr 9Senate Second Reading Passed - No AmendmentsMinor
- Apr 8Senate Second Reading Laid Over to 04/09/2026 - No Amendments
- Apr 2Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the WholeMinor
- Vote recorded Refer Senate Bill 26-140 to the Committee of the Whole. Result: pass.Upper
- Mar 16Introduced In Senate - Assigned to Health & Human ServicesIntroduced
- Apr 22House Committee on Health & Human Services Postpone IndefinitelyLatest